Sourcewave

Therapeutic Bio-Frequency Patches

Sourcewave is a portfolio company of RTG

SOURCEWAVE has developed technology to imprint proprietary material with electromagnetic signatures to mimic consuming substances to the human body.

Their technology has been in development for almost 13 years. By mimicking how cells interpret electromagnetic signatures of molecules, the technology works by imprinting a biocentric material with information signatures that the body signals as actually consuming the physical substance.

There are no side effects, there is no waste, costs are reduced, and using the product results in heavily increased efficiency in biological systems.

Studies with the FDA have just begun in order to make medical claims.

Sourcewave
TECHNOLOGIES

Portfolio Companies

Subscribe and be the first to know

about exciting developments in how we are changing the world.